Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024530 (
malaria
)
44,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Plasma membrane Ca
2+
-ATPases are key calcium exporter proteins in most tissues, and
PMCA4b
is the main calcium transporter in the human red blood cells (RBCs). In order to assess the expression level of
PMCA4b
, we have developed a flow cytometry and specific antibody binding method to quantitatively detect this protein in the erythrocyte membrane. Interestingly, we found several healthy volunteers showing significantly reduced expression of RBC-
PMCA4b
. Western blot analysis of isolated RBC membranes confirmed this observation, and indicated that there are no compensatory alterations in other PMCA isoforms. In addition, reduced
PMCA4b
levels correlated with a lower calcium extrusion capacity in these erythrocytes. When exploring the potential genetic background of the reduced
PMCA4b
levels, we found no missense mutations in the ATP2B4 coding regions, while a formerly unrecognized minor haplotype in the predicted second promoter region closely correlated with lower erythrocyte
PMCA4b
protein levels. In recent GWA studies, SNPs in this ATP2B4 haplotype have been linked to reduced mean corpuscular hemoglobin concentrations (MCHC), and to protection against
malaria
infection. Our data suggest that an altered regulation of gene expression is responsible for the reduced RBC-
PMCA4b
levels that is probably linked to the development of human disease-related phenotypes.
...
PMID:Decreased calcium pump expression in human erythrocytes is connected to a minor haplotype in the ATP2B4 gene. 2821 81